COST-EFFECTIVENESS ANALYSIS OF ARIPIPRAZOLE COMPARED WITH RISPERIDONE IN TREATMENT OF ACUTE SCHIZOPHRENIA PATIENTS IN THAILAND

Authors

Wiwat Thavornwattanayong

Abstract

OBJECTIVES: Schizophrenia is the third leading cause of loss of life years in Thailand. Currently, aripiprazole is the latest drug for the treatment of acute schizophrenia in Thailand but its cost-effectiveness has not been studied. The purpose of this s.

DOI

10.56808/3027-7922.2379

First Page

169

Last Page

175

Recommended Citation

Thavornwattanayong, Wiwat (2018) "COST-EFFECTIVENESS ANALYSIS OF ARIPIPRAZOLE COMPARED WITH RISPERIDONE IN TREATMENT OF ACUTE SCHIZOPHRENIA PATIENTS IN THAILAND," The Thai Journal of Pharmaceutical Sciences: Vol. 42: Iss. 3, Article 8.
DOI: https://doi.org/10.56808/3027-7922.2379
Available at: https://digital.car.chula.ac.th/tjps/vol42/iss3/8